Why does the sepsis induced by severe COVID-19 have different clinical features from sepsis induced by CrKP?

by Hong-Yuan Lin
Published 2022-01-01

The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy

by Hong-Yuan Lin
Published 2020-08-01

Why anticoagulant studies on sepsis fail frequently --- start with SCARLET

by Jian-Ying Guo, Hong-Yuan Lin
Published 2023-09-01

Eriodictyol decreases very late antigen-4 (VLA-4) expression, cellular adhesion, and migration through an NFκB-dependent pathway in monocytes

by Tzou-Chi Huang, Kuo Yao Tseng, Shinn-Shyong Tsai, Hung-Jen Liu, Chi-Tang Ho, Hong Yuan Lin, Li Ting Cheng, Kuo Pin Chuang
Published 2010-10-01

Expert consensus on the monitoring and treatment of sepsis-induced immunosuppression

by Fei Pei, Ren-Qi Yao, Chao Ren, Soheyl Bahrami, Timothy R. Billiar, Irshad H. Chaudry, De-Chang Chen, Xu-Lin Chen, Na Cui, Xiang-Ming Fang, Yan Kang, Wei-Qin Li, Wen-Xiong Li, Hua-Ping Liang, Hong-Yuan Lin, Ke-Xuan Liu, Ben Lu, Zhong-Qiu Lu, Marc Maegele, Tian-Qing Peng, You Shang, Lei Su, Bing-Wei Sun, Chang-Song Wang, Jian Wang, Jiang-Huai Wang, Ping Wang, Jian-Feng Xie, Li-Xin Xie, Li-Na Zhang, Basilia Zingarelli, Xiang-Dong Guan, Jian-Feng Wu, Yong-Ming Yao, the Shock and Sepsis Society of Chinese Research Hospital Association, the China Critical Care Immunotherapy Research Group, the International Federation of the Shock Societies (IFSS)
Published 2022-12-01